DICE supports companies in the delivery of phase 1 to phase 4 studies and rescue studies. We have over 25 years experience in different therapeutic areas, technologies and target groups. We have successfully worked together with several pharmaceutical start-ups from phase 1 until market launch and defended their studies for FDA & EMA.

Therapeutic area

  • Ophtalmology
  • Oncology
  • Autoimmune diseases
  • Diabetes
  • Haematology
  • Metabolic diseases
  • Neurology
  • Urology
  • Endocrinology
  • Gastroenterology
  • Pneumology
  • Pediatric diseases

Technology

  • Molecular
  • Biologicals
  • Immunotherapeutics
  • Medical devices
  • Cell therapy
  • Genetics

Target Group

  • Pediatrics
  • Andrology
  • Gynaecology
  • Orphan diseases